Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| P01AT004952 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Center for Complementary and Integrative Health (NCCIH) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Wisconsin Center for the Neuroscience and Psychophysiology of Meditation will be a highly focused center dedicated to novel and cutting edge research on the mechanisms by which meditation works. The core set of hypotheses for this Center focus on the mechanisms of two common meditation practices: Mindfulness Meditation (MM) and Loving-Kindness/Compassion Meditation (LKM-CO), both taught in Mindfulness-Based Stress Reduction (MBSR). The investigators will study both Long-Term Meditators (LTMs) as well as meditation-naïve participants (MNPs). The latter group will be randomly assigned to MBSR, a rigorously matched comparison intervention called the Health Enhancement Program (HEP; MacCoon et al., 2012), or to a Wait List (WL) control group. This will give us a comprehensive view of changes that are produced by meditation practices per se, changes generically associated with interventions designed to promote well-being, and changes that might be effects of repeating testing protocols across multiple occasions. In addition, the inclusion of both novice and experienced meditators provides a wide range of practice experience that will provide critical information on dose-related effects, information that is lacking in the research literature today.
Each of the projects is focused on examining the brain mechanisms and peripheral biological correlates of meditation. Project 1 (Davidson) will examine the impact of the explicit use of mindfulness and loving-kindness/compassion strategies on emotion regulation, specifically neural, biobehavioral and hormonal indices of reactivity to and recovery from pictures of human suffering and flourishing. Project 2 (Rosenkranz) will investigate the brain to periphery pathways through which psychological factors contribute to the expression of asthma symptoms. In addition, it will examine the efficacy of meditation training in reducing the inflammatory response to an allergen in asthmatic individuals by reducing the reactivity of emotion-related neural circuitry. Project 3 (Tononi) will examine whether the previously reported increase in gamma oscillations during Non-REM (NREM) sleep in meditators is associated with changes in sleep mentation (Ferrarelli et al. 2013). In addition, project 3 will examine relations between meditation-induced changes in brain activity during sleep and brain activity and cognitive function during wakefulness.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MNP with Asthma: Mindfulness Based Stress Reduction | Active Comparator |
| |
| MNP w/ Asthma: Wait List Control | No Intervention | ||
| MNP, no asthma - Mindfulness Based Stress Reduction | Active Comparator |
| |
| MNP, no asthma: Health Enhancement Program | Active Comparator |
| |
| MNP, no asthma - Wait List Control | No Intervention | ||
| Long Term Meditator | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intensive Meditation Practice | Behavioral | Long term meditators complete three days of of mindfulness or compassion/loving kindness meditation at T2 and T3 (one meditation type per visit). |
| Measure | Description | Time Frame |
|---|---|---|
| Change in temporal dynamics of response to emotional anticipation task (fMRI) as a result of short term meditation practice OR 8 week training in meditation or health wellness interventions. | baseline, 3 months, 10 months | |
| Change in slope measure of diurnal cortisol following a well-being intervention relative to baseline. | baseline (pre-intervention), 3 months (post-intervention), 10 months (follow-up) | |
| Difference between groups (MBSR, WL) on change in lung function from pre-training to post-training | baseline (pre), 3 months (post-intervention) |
Not provided
Not provided
Inclusion Criteria - MNP-A:
Exclusion Criteria - MNP-A:
Pregnant, wanting to become pregnant, breast feeding or less than 6 months post-partum.
Taking prescribed psychotropic or central nervous system altering medications (may be included with the PIs discretion).
History of a diagnosed Bipolar Disorder, Schizophrenia, or Schizoaffective Disorder. Diagnosed episode of Major Depression unless it was more than 1 year ago. Diagnosed eating disorder or anxiety disorder unless it was more than 1 year ago. (May be included with the PIs discretion).
Excluded based upon the screening visit
Some ongoing medical problems will be excluded based on team judgments about whether they will affect a participant's ability to participate in the study procedures or will affect one or more outcome measures.
Unable to distinguish colors used in Stroop task
Use of oral corticosteroids
Inability or unwillingness to withhold medication as detailed below, before each set of laboratory assessments:
Use of >1000 mcg Fluticasone or equivalent ICS per day.
Use of monoclonal antibody that targets eosinophils
Concurrent medications other than for allergies/asthma (must be approved by Dr.)
Current smoker or has a smoking history exceeding 5 pack-years within the last 10 years (i.e. someone who has been a non-smoker for 10 or more years can be enrolled)
Significant previous training or significant current practice in meditation
Significant daily practice with other mind-body techniques
Inclusion Criteria - MNP-NA:
Exclusion Criteria - MNP-NA:
Pregnant, wanting to become pregnant, breast feeding or less than 6 months post-partum.
Taking prescribed psychotropic or central nervous system altering medications (may be judged by PI in cases of periodic use (e.g. takes anti-anxiety med only when flying)
History of a diagnosed Bipolar Disorder, Schizophrenia, or Schizoaffective Disorder. Diagnosed episode of Major Depression unless it was more than 1 year ago. Diagnosed eating disorder or anxiety disorder unless it was more than 1 year ago.
Excluded based upon the screening visit
Some ongoing medical problems will be excluded based on team judgments about whether they will affect a participant's ability to participate in the study procedures or will affect one or more outcome measures.
Unable to distinguish colors used in Stroop task
Currently participating in another clinical trial
Current diagnosis of asthma unless. History of asthma is not cause for exclusion.
Taking prescribed sleeping medications (may be judged by sleep doctor in cases of periodic use (e.g. takes sleep med only when traveling internationally))
Currently diagnosed sleep disorders. Past disorders are a judgment by a doctor from the sleep clinic.
Regular night shift worker. (Participants may work periodic night shifts (e.g. one rotation per month) as long as they are able to sleep at normal times for the study)
Epworth Sleepiness Scale - sleep lab will judge focusing on whether this a situational or chronic issue (e.g. dogs waking up vs. awake due to anxiety).
Insomnia Severity Index - sleep lab will judge focusing on whether this a situational or chronic issue (e.g. dogs waking up vs. awake due to anxiety).
STOP-BANG questionnaire - sleep lab will judge focusing on whether this is a situational or chronic issue (unless question 3 = yes in which case a score >3 will be excluded).
Cigarette smoker unless willing to go without a cigarette for 4 hours or more.
Traveled across more than 3 time zones in the three weeks prior to each study visit.
Expert in physical activity (e.g. physical therapist, personal trainer), music (music therapist) or nutrition (nutritionist).
Significant daily practice with physical activity as scored by the web screen.
Significant previous training or significant current practice in meditation
Significant daily practice with other mind-body techniques
Inclusion Criteria - LTM:
Exclusion Criteria - LTM:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Richard J Davidson, PhD | UW-Madison, Center for Investigating Healthy Minds at the Waisman Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UW Madison, Center for Investigating Healthy Minds at the Waisman Center | Madison | Wisconsin | 53705 | United States | ||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36177306 | Derived | Higgins ET, Davidson RJ, Busse WW, Klaus DR, Bednarek GT, Goldman RI, Sachs J, Rosenkranz MA. Clinically relevant effects of Mindfulness-Based Stress Reduction in individuals with asthma. Brain Behav Immun Health. 2022 Sep 14;25:100509. doi: 10.1016/j.bbih.2022.100509. eCollection 2022 Nov. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Mindfulness Based Stress Reduction | Behavioral | 8 week class designed to enhance well-being through training in mindfulness. |
|
|
| Health Enhancement Program | Behavioral | 8 week class designed to enhance well-being through training in physical activity, functional movement, music therapy and nutrition. |
|
|
| UW-Madison, Asthma, Allergy and Pulmonary Research Center |
| Madison |
| Wisconsin |
| 53705 |
| United States |
| UW-Health Sports Medicine & Integrative Medicine Program | Madison | Wisconsin | 53711 | United States |
| Center for Sleep and Consciousness (and Wisconsin Sleep Clinic) | Madison | Wisconsin | 53719 | United States |
| ID | Term |
|---|---|
| D000092862 | Psychological Well-Being |
| D001249 | Asthma |
| ID | Term |
|---|---|
| D010549 | Personal Satisfaction |
| D001519 | Behavior |
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012130 | Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000099024 | Mindfulness-Based Stress Reduction |
| ID | Term |
|---|---|
| D064866 | Mindfulness |
| D015928 | Cognitive Behavioral Therapy |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided